D-0249-2025 Class II Ongoing
FDA drug recall D-0249-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Feb 6, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 9840 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 12, 2025
- Initiation Date
- Feb 6, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9840 bottles
Product description
Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide within in the USA.
Code information
Lot #: AD16615, Exp. Date 07/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0249-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026